ReviewPharmaceuticals (Basel, Switzerland)2026

Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer Immunotherapy.

Su-Jin Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.